Physician profile
Bruce E West
NPI 1629077763
$908.57
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $197 · 2021: $287 · 2022: $162.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $361.47 | 2019-2022 | |
| Myovant Sciences INC. | $117.86 | 2021-2022 | |
| Daiichi Sankyo INC. | $89.31 | 2019-2021 | |
| Avion Pharmaceuticals | $79.24 | 2019-2021 | |
| Coopersurgical, INC. | $57.23 | 2019-2022 | |
| Therapeuticsmd, INC. | $39.12 | 2019-2021 | |
| Allergan, INC. | $36.84 | 2019 | |
| Shield Therapeutics INC | $32.70 | 2022 | |
| Lupin INC. | $26.54 | 2020 | |
| Hologic Sales and Service, LLC | $22.78 | 2020 | |
| Mayne Pharma Commercial LLC | $17.20 | 2021 | |
| Mylan Pharmaceuticals INC. | $15.56 | 2022 | |
| Dysis Medical, INC. | $12.72 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.